tmr修改
This commit is contained in:
@@ -119,6 +119,10 @@ function side_list() {
|
||||
console.log($('.Gue_special').length)
|
||||
|
||||
|
||||
if (Jour_num == 1) {
|
||||
|
||||
$('.Join_Bord2').css('display', 'block')
|
||||
}
|
||||
localStorage.setItem("Journals_title", arr_jour.title);
|
||||
localStorage.setItem("Journals_issn", arr_jour.issn);
|
||||
localStorage.setItem("Journals_color", arr_jour.system_color);
|
||||
@@ -126,6 +130,7 @@ function side_list() {
|
||||
$('.About_Journal').attr('href', 'about_journal.html?J_num=' + Jour_num);
|
||||
$('.Ins_authors').attr('href', 'for_author.html?J_num=' + Jour_num);
|
||||
$('.Join_Bord').attr('href', 'z_f6-1.html?J_num=' + Jour_num);
|
||||
$('.Join_Bord2').attr('href', 'z_f11-1.html?J_num=' + Jour_num);
|
||||
$('.edit_board_tmr>a').attr('href', arr_jour.board_url);
|
||||
$('.edit_board_tmr').after('<p><b>Impact Factor (Clarivate):</b> <span>1.3</span></p>');
|
||||
//$('.edit_board_tmr>a').attr('href', 'notice.html?J_num=' + Jour_num + '&footer_id=' + arr_jour.board_url);
|
||||
@@ -135,7 +140,7 @@ function side_list() {
|
||||
var arr_Abc = result.data.journalAbs;
|
||||
var str = "";
|
||||
for (var i = 0; i < arr_Abc.length; i++) {
|
||||
if(arr_Abc[i].is_show==1){
|
||||
if (arr_Abc[i].is_show == 1) {
|
||||
str += '<li>» <a target="_blank" href="' + arr_Abc[i].url + '">' + arr_Abc[i].title + '</a></li>'
|
||||
}
|
||||
}
|
||||
|
||||
@@ -75,6 +75,12 @@
|
||||
<a href="" class="rgb_color Join_Bord" target="_blank">Join<br>Editorial Board</a>
|
||||
<br clear="both">
|
||||
</div>
|
||||
<a href="" style="display: none; font-size: 14px;
|
||||
line-height: 20px;
|
||||
|
||||
padding: 10px 0 5px 0;
|
||||
height: 45px" class="rgb_color_background Join_Bord2" target="_blank">Publication Ethics and<br>
|
||||
Malpractice Statement</a>
|
||||
</div>
|
||||
|
||||
<!-- <div class="Tmr_lian_jie" style="display: none">-->
|
||||
|
||||
768
z_f11-1.html
Normal file
768
z_f11-1.html
Normal file
@@ -0,0 +1,768 @@
|
||||
<!doctype html>
|
||||
<html lang="zh">
|
||||
<head>
|
||||
<meta charset="UTF-8">
|
||||
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
|
||||
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
|
||||
<title></title>
|
||||
<link rel="shortcut icon" href="img/tmr3.png" type="image/x-icon"/>
|
||||
<link rel="stylesheet" type="text/css" href="style/font-awesome/css/font-awesome.min.css">
|
||||
<link rel="stylesheet" type="text/css" href="style/style.css"/>
|
||||
<style>
|
||||
.topics {
|
||||
font-family: Calibri;
|
||||
font-size: 17px;
|
||||
}
|
||||
.topics>div a:hover {
|
||||
color: rgb(0, 71, 178)!important;
|
||||
text-decoration: underline;
|
||||
}
|
||||
|
||||
.topics>div a {
|
||||
/* font-weight: bold; */
|
||||
color: rgb(0, 71, 178);text-decoration: underline;
|
||||
}
|
||||
.topics>div p {
|
||||
margin-block-start: 1em;
|
||||
margin-block-end: 1em;
|
||||
margin-inline-start: 0px;
|
||||
margin-inline-end: 0px;
|
||||
unicode-bidi: isolate;
|
||||
}
|
||||
|
||||
.item-title {
|
||||
font-size: 20px;
|
||||
margin-bottom: 5px;
|
||||
font-weight: bold;
|
||||
}
|
||||
.big{
|
||||
font-size: 24px;
|
||||
}
|
||||
.topics ul {
|
||||
list-style-type: circle;
|
||||
padding-left: 20px;
|
||||
margin-top: 0;
|
||||
}
|
||||
.topics ul li {
|
||||
text-align: left;
|
||||
width: 100%;
|
||||
float: none;
|
||||
list-style-type:disc;
|
||||
margin-bottom: 0;
|
||||
}
|
||||
.fuwenben img{
|
||||
max-width: 100%;
|
||||
margin: 0 auto;
|
||||
display: block;
|
||||
}
|
||||
</style>
|
||||
</head>
|
||||
<body>
|
||||
<div id="col-content">
|
||||
<div id="top_bar">
|
||||
<!--头部-->
|
||||
</div>
|
||||
<div class="article">
|
||||
<div class="art_side">
|
||||
|
||||
<!--侧边栏-->
|
||||
|
||||
</div>
|
||||
|
||||
<div class="art_main art_main_con back_fff">
|
||||
<div class="topics fuwenben">
|
||||
<h2 class="rgb_color">Publication Ethics and Malpractice Statement</h2>
|
||||
<div style="padding: 0 30px;line-height: 24px;text-align: justify;">
|
||||
|
||||
<p class="item-title big">Responsible use of AI language models (ChatGPT)</p>
|
||||
|
||||
<p> TMR Publishing Group places great importance on the quality and reliability of academic
|
||||
research
|
||||
while also welcoming authors to use various effective tools and techniques to enhance their
|
||||
research efficiency and quality. When using artificial intelligence language models such as
|
||||
ChatGPT, we believe that authors must be cautious about the semantic understanding it
|
||||
generates
|
||||
and the ambiguities caused by cultural differences to ensure that the use of these tools
|
||||
does
|
||||
not affect the quality and reliability of the research.
|
||||
</p>
|
||||
<p> Therefore, TMR Publishing Group allows authors to use ChatGPT to improve efficiency in
|
||||
translation, summarization, language correction, etc. but does not allow authors to use
|
||||
ChatGPT
|
||||
to generate the main content of their research papers. If an author is found to have
|
||||
violated
|
||||
this rule, the article will be rejected, and any manuscripts submitted by the author will
|
||||
not be
|
||||
accepted by any TMR Publishing Group journals for two years. We hope that the authors can
|
||||
understand our position and comply with our regulations.</p>
|
||||
<p class="item-title"> Editorial policy</p>
|
||||
|
||||
<p> We are doing our best to practice the ethics and policy of <a target="_blank"
|
||||
href="https://publicationethics.org/">COPE
|
||||
(Committee on Publication
|
||||
Ethics)</a>, <a target="_blank" href="https://www.icmje.org/"></a>ICMJE (International
|
||||
Committee of Medical Journal Editors)</a>, and <a target="_blank"
|
||||
href="https://www.icmje.org/">DOAJ (Directory of
|
||||
Open
|
||||
Access Journals)</a>. TMR Publishing Group has an internal online monitoring system to
|
||||
regulate
|
||||
the
|
||||
journals following the Ethics and Policy stated on the website.
|
||||
TMR Publishing Group follows <a target="_blank"
|
||||
href="https://publicationethics.org/resources/guidelines/principles-transparency-and-best-practice-scholarly-publishing">the
|
||||
sixteen principles of
|
||||
transparency developed by the
|
||||
Committee on Publication Ethics (COPE)</a>.
|
||||
</p>
|
||||
|
||||
<p class="item-title"> Authorship and contributorship</p>
|
||||
|
||||
<p> We adopt the four criteria recommended by <a target="_blank"
|
||||
href="https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html">ICMJE
|
||||
(International
|
||||
Committee of Medical Journal
|
||||
Editors)</a>.</p>
|
||||
<p> Only individuals who contributed significantly to one or more of the following can be listed
|
||||
as
|
||||
authors:</p>
|
||||
<p> (1). Substantial contributions to the conception or design of the work; or the acquisition,
|
||||
analysis, or interpretation of data for the work; AND</p>
|
||||
|
||||
<p>(2). Drafting the work or revising it critically for important intellectual content; AND
|
||||
</p>
|
||||
<p>(3). Final approval of the version to be published; AND
|
||||
</p>
|
||||
<p> (4). Agreement to be accountable for all aspects of the work in ensuring that questions
|
||||
related
|
||||
to the accuracy or integrity of any part of the work are appropriately investigated and
|
||||
resolved.<br /> Contributors who do not meet the criteria for authorship, but who have
|
||||
nevertheless contributed
|
||||
to the project, should be acknowledged in the Acknowledgements section. This may include
|
||||
individuals who provided technical help, editorial assistance, or significant administrative
|
||||
support, such as department leaders who aided the research process. Additionally,
|
||||
acknowledgements should extend to those who have contributed resources or funding. Consent
|
||||
should be obtained from these contributors before they are acknowledged to ensure
|
||||
transparency
|
||||
and respect for their privacy.</p>
|
||||
<p class="item-title"> Comments and complaints</p>
|
||||
<p> Readers with concerns or complaints about published article should contact the corresponding
|
||||
author directly to attempt resolution before contacting the editorial office. In cases where
|
||||
it
|
||||
is inappropriate to contact the author, the author has not responded, or the concerns have
|
||||
not
|
||||
been resolved, the editor's office can be contacted. The editorial office will coordinate
|
||||
with
|
||||
complainants, authors and editor-in-chief or editorial board members, with reference to
|
||||
<a target="_blank"
|
||||
href="https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html">COPE's
|
||||
general rules of practice, to investigate, remedy or resolve any concerns or
|
||||
complaints</a>.
|
||||
</p>
|
||||
<p class="item-title"> Allegations of research misconduct</p>
|
||||
|
||||
|
||||
|
||||
<p> We are committed to maintaining the highest standards of integrity in academic publishing,
|
||||
in
|
||||
accordance with the <a target="_blank"
|
||||
href="https://publicationethics.org/misconduct">Committee on Publication Ethics
|
||||
(COPE)</a>.
|
||||
Our policy defines research
|
||||
misconduct to include fabrication, falsification, and plagiarism. We conduct an immediate,
|
||||
confidential assessment of any allegations of misconduct. If necessary, a detailed
|
||||
investigation
|
||||
is carried out by an impartial committee, which may lead to corrections, retractions, or
|
||||
other
|
||||
appropriate actions. Throughout the process, we ensure confidentiality and provide a
|
||||
mechanism
|
||||
for appeals.</p>
|
||||
|
||||
|
||||
<p class="item-title"> Conflicts of interest</p>
|
||||
|
||||
|
||||
|
||||
|
||||
<p> At the end of the text, under the subheading 'Conflict of interest statement', all authors
|
||||
must
|
||||
disclose any financial and personal relationships with other people or organisations that
|
||||
could
|
||||
inappropriately influence (bias) their work. Examples of potential conflicts of interest
|
||||
include
|
||||
employment, consultancies, stock ownership, honoraria, paid expert testimony, patent
|
||||
applications/registrations, and grants or other funding.
|
||||
</p>
|
||||
|
||||
<p class="item-title"> Data sharing and reproducibility</p>
|
||||
|
||||
<p> Authors are encouraged to share their data in a manner consistent with ethical
|
||||
considerations
|
||||
and legal restrictions. Statistical methods and experimental protocols must be sufficiently
|
||||
detailed in the manuscripts to allow replication.</p>
|
||||
|
||||
|
||||
<p class="item-title">Ethical oversight</p>
|
||||
<p>All research published in all journals of TMR Publishing Group must be conducted according to
|
||||
international and local guidelines ensuring ethically conducted research. If the
|
||||
experimental or
|
||||
clinical research does not meet the ethical standards of the journal, the manuscript will be
|
||||
rejected without delay.</p>
|
||||
|
||||
<p class="item-title"></p>1. Studies in animals
|
||||
<p>The manuscript for research involving animals (whether living or tissue) must include a
|
||||
statement providing information about the ethics committee that approved the research and,
|
||||
if
|
||||
available, the license or animal license number. This number must be clearly stated in the
|
||||
methods section.<br />If the research was approved by the ethics committee but did not
|
||||
receive an ethics approval
|
||||
number due to special circumstances, the author must include the original official approval
|
||||
document and its English translation as supplementary materials for the manuscript. If the
|
||||
research has been granted ethical approval for exemption, the name of the ethics committee
|
||||
granting the exemption and the reason for the exemption must be stated.
|
||||
<p></p>The research must be conducted in accordance with internationally recognized principles
|
||||
for the
|
||||
use and care of laboratory animals, such as those outlined in <a target="_blank"
|
||||
href="https://publicationethics.org/misconduct">the
|
||||
Guide for the Care and Use of
|
||||
Laboratory Animals: Eighth Edition (Washington, DC: The National Academies Press)</a>. The
|
||||
editors
|
||||
may reject a manuscript if there are any concerns about the appropriateness of the animal
|
||||
procedures used.</p>
|
||||
|
||||
|
||||
<p class="item-title">2. Studies in humans</p>
|
||||
<p>Research involving humans, including observational and survey-based studies, as well as any
|
||||
personal data collection, must comply with the <a target="_blank"
|
||||
href="https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/">Declaration
|
||||
of
|
||||
Helsinki</a> and must have been
|
||||
approved by a suitable ethics committee. The research must also have been approved by the
|
||||
institutional human experimentation committee or equivalent, and informed consent must have
|
||||
been
|
||||
obtained from participants. The ethical approval number must be clearly stated in the
|
||||
methods
|
||||
section. In cases where the research has been approved by the institutional human
|
||||
experimentation committee or equivalent but has not received an ethics approval number due
|
||||
to
|
||||
special circumstances, the author must include the original official approval document and
|
||||
its
|
||||
English translation as supplementary materials for the manuscript.
|
||||
<br />Ethical considerations in the design of different human research:
|
||||
|
||||
</p>
|
||||
<p class="item-title">a. Retrospective research:</p>
|
||||
<p> If the research involves accessing or using personal data, such as medical records or other
|
||||
sensitive information, ethical approval is required. Researchers must carefully consider the
|
||||
ethical implications of their research and seek guidance from appropriate committees or
|
||||
review
|
||||
boards if necessary to ensure that their research is conducted in an ethical and responsible
|
||||
manner. If ethical approval for the article is waived, documentation of approval from an
|
||||
ethics
|
||||
committee must be provided and a statement confirming this must be included in the
|
||||
manuscript. <br />
|
||||
Unless the owner of the content in the database has other suggestions, the obtained data
|
||||
must
|
||||
remain anonymous. If the detailed information of the participants does not need to be
|
||||
anonymous,
|
||||
the authors must be able to provide evidence that written informed consent has been obtained
|
||||
from the participants, including consent to publication. A statement confirming this must be
|
||||
included in the manuscript.</p>
|
||||
<p class="item-title"> b. Investigative research:</p>
|
||||
<p> Researchers must ensure that they have informed all participants of the reasons for the
|
||||
research, whether anonymity is guaranteed, and how the data they collect is stored.
|
||||
Participants' confidentiality rights should always be considered and they should be fully
|
||||
informed of the purpose of the research and whether there are any associated risks. Their
|
||||
voluntary consent should be recorded and any legal requirements regarding data protection
|
||||
should
|
||||
be complied with. As with all research, ethical approval from the appropriate local ethics
|
||||
committee must be obtained prior to conducting research. A statement confirming this must be
|
||||
included in the manuscript. In cases where ethical approval of an investigative study is not
|
||||
required, authors must include a statement explaining this in the manuscript.
|
||||
</p>
|
||||
<p class="item-title"> c. Research involving organ and tissue transplantation:</p>
|
||||
<p> TMR Publishing Group endorses the ethical guidelines set forth by the <a target="_blank"
|
||||
href="">World Health
|
||||
Organization
|
||||
(WHO)</a> and <a target="_blank"
|
||||
href="https://journals.lww.com/transplantjournal/fulltext/2010/08150/WHO_Guiding_Principles_on_Human_Cell,_Tissue_and.1.aspx">the
|
||||
World Medical Association (WMA)</a>. All
|
||||
research involving the transplantation of
|
||||
human organs should have ethical approval from the appropriate committee and the source of
|
||||
donor
|
||||
tissue must be disclosed in the manuscript. If the donor is deceased, the authors must
|
||||
verify
|
||||
that the donated organ was obtained with the fully informed consent of the donor or a close
|
||||
relative. Consent must be given willingly and must not be influenced by coercion or bribes.
|
||||
The
|
||||
manuscript must include a statement specifying the source of the transplanted organ and a
|
||||
confirmation that informed consent was obtained.</p>
|
||||
<p class="item-title">d. Research involving children, adolescents, and vulnerable or
|
||||
incapacitated research
|
||||
participants:</p>
|
||||
<p> Written informed consent must be obtained from the parent or guardian of any participant who
|
||||
is
|
||||
unable to provide full informed consent themselves. The legal age of majority varies by
|
||||
country
|
||||
and is generally between 16-18 years old. The manuscript must include a statement confirming
|
||||
that informed consent was obtained. If oral informed consent was obtained instead of written
|
||||
consent, this must be explained and documented in the manuscript. In accordance with the
|
||||
principles outlined in the <a target="_blank"
|
||||
href="https://www.cirp.org/library/ethics/nuremberg/">Nuremberg Code</a> and the <a
|
||||
target="_blank"
|
||||
href="https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/read-the-belmont-report/index.html">Belmont
|
||||
Report</a>, informed consent must be
|
||||
given
|
||||
voluntarily and without coercion or bribes.</p>
|
||||
|
||||
<p class=""> 3.Informed consent and patient details</p>
|
||||
<p>
|
||||
TMR Publishing Group endorses the <a target="_blank"
|
||||
href="https://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html">recommendations
|
||||
of the
|
||||
International Committee of Medical
|
||||
Journal Editors (ICMJE)</a>, which emphasizes that patients and study participants have
|
||||
a right
|
||||
to
|
||||
privacy that should not be violated without informed consent.
|
||||
<br />
|
||||
According to the principles outlined in the <a target="_blank"
|
||||
href="https://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html">Nuremberg
|
||||
Code</a>
|
||||
and <a target="_blank"
|
||||
href="https://www.legislation.govt.nz/act/public/1994/0088/latest/whole.html">the Health
|
||||
and Disability
|
||||
Commissioner Act 1994</a>, <a target="_blank"
|
||||
href="https://www.hdc.org.nz/your-rights/about-the-code/code-of-health-and-disability-services-consumers-rights/">the
|
||||
Code of Health and Disability Services Consumers' Rights</a>, and
|
||||
<a target="_blank"
|
||||
href="https://www.legislation.govt.nz/act/public/1993/0028/latest/whole.html"> the
|
||||
Privacy Act 1993</a>, informed consent from participants must be obtained voluntarily,
|
||||
and
|
||||
participants should be fully informed about the research, including any benefits and risks
|
||||
involved.
|
||||
<br />
|
||||
For all research involving human subjects, written informed consent must be obtained before
|
||||
the
|
||||
start of the study and must be included in the manuscript as a statement confirming that
|
||||
this
|
||||
has been done. The author must retain written consent from patients, and the editorial
|
||||
office
|
||||
will ask the author to provide it in case of need, such as legal disputes, challenges, or
|
||||
complaints. For research involving children, in addition to obtaining the informed consent
|
||||
of
|
||||
the parent or legal guardian, assent from the child should also be obtained in a manner
|
||||
appropriate to the child's age, maturity, and level of understanding. Special consideration
|
||||
should be given to the protection of vulnerable populations, such as children, pregnant
|
||||
women,
|
||||
prisoners, and individuals with mental or physical disabilities. These individuals may
|
||||
require
|
||||
additional safeguards to protect their rights and well-being and may require the involvement
|
||||
of
|
||||
an advocate or legal guardian in the informed consent process. If the participant is
|
||||
deceased,
|
||||
consent must be obtained from their legal guardian or close relative.
|
||||
<br />
|
||||
The following informed consent policy must be followed for any articles and supplementary
|
||||
materials (including all illustrations and videos) that contain information that may
|
||||
identify a
|
||||
patient's personal details:<br />
|
||||
Authors must confirm that they have obtained access to the affected individual (or their
|
||||
parent/guardian, if the participant is not an adult or unable to give informed consent; or
|
||||
a
|
||||
close relative if the participant is deceased).<br />
|
||||
Identifying information includes (but is not limited to) written descriptions, photographs,
|
||||
illustrations, audio recordings, videos, family trees and rare diseases, physical
|
||||
characteristics or diseases.<br />
|
||||
The process of obtaining consent to publish should include sharing the article with
|
||||
individuals
|
||||
(or anyone giving consent on their behalf) so that they fully understand the content of the
|
||||
article before publication. A statement of consent to publish must confirm that the
|
||||
individual
|
||||
giving consent is aware of and agrees to the release of specific details, such as images,
|
||||
videos, audio recordings, etc., and has been informed of the content of the article to be
|
||||
published.<br />
|
||||
</p>
|
||||
<p class="item-title"> 4.Clinical case report</p>
|
||||
<p>
|
||||
A clinical case report provides a detailed account of an individual patient's clinical
|
||||
experiences. As the manuscript may contain sensitive personal information, obtaining
|
||||
explicit
|
||||
consent is necessary for its publication.
|
||||
<br />
|
||||
To ensure proper ethical conduct, authors must confirm that they have obtained permission to
|
||||
include information about the affected individual (or their parent/guardian if the
|
||||
participant
|
||||
is not an adult or unable to give informed consent; or a close relative if the participant
|
||||
is
|
||||
deceased).<br />
|
||||
|
||||
For thorough reporting, we recommend following the <a target="_blank"
|
||||
href="https://www.care-statement.org/">CARE
|
||||
guidelines</a>.
|
||||
<br />
|
||||
</p>
|
||||
<p class="item-title"> 5.Clinical trial results</p>
|
||||
<p class="item-title"> a.Registration of clinical trials</p>
|
||||
<p>
|
||||
We follow the <a target="_blank" href="https://www.care-statement.org/">ICMJE description of
|
||||
the clinical trial</a>.<br />
|
||||
In accordance with the <a target="_blank"
|
||||
href="https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html">recommendations
|
||||
of the ICMJE</a>, clinical
|
||||
trials must be registered in a
|
||||
public trials registry prior to publication in this journal. The trial registration number
|
||||
and
|
||||
registration date must be included in the abstract and methods sections of the manuscript,
|
||||
and
|
||||
any deviations from the original trial protocol must be explained.<br />
|
||||
Trials must register at or before the onset of patient enrolment. Purely observational
|
||||
studies
|
||||
will not require registration. Clinical trial protocols must be registered in a publicly
|
||||
accessible registry prior to participant recruitment. Public registration must be open to
|
||||
all
|
||||
potential registrants and administered by a non-profit organization. A list of eligible
|
||||
registries can be found on the <a target="_blank"
|
||||
href="https://www.who.int/clinical-trials-registry-platform">WHO International Clinical
|
||||
Trials
|
||||
Registry Platform (ICTRP)</a>.
|
||||
Trials can also be registered at <a target="_blank"
|
||||
href="https://clinicaltrials.gov/">Clinical Trials.gov</a> or the <a target="_blank"
|
||||
href="https://www.clinicaltrialsregister.eu/">EU
|
||||
Clinical Trials
|
||||
Register</a>.<br />
|
||||
|
||||
</p>
|
||||
|
||||
<p class="item-title"> b.Reporting clinical trials</p>
|
||||
<p> We strongly encourage authors of randomized controlled trial studies to follow the CONSORT
|
||||
guidelines in order to improve the quality and clarity of their research reports. Adhering
|
||||
to
|
||||
these guidelines can help to ensure that key information about the study design, participant
|
||||
characteristics, interventions, and outcomes is accurately and completely presented,
|
||||
allowing
|
||||
readers to fully understand and evaluate the study. While following the CONSORT guidelines
|
||||
is
|
||||
not a requirement, we believe that doing so can significantly enhance the value and impact
|
||||
of
|
||||
the research for the scientific community.</p>
|
||||
|
||||
<p class="item-title"> 6.Research involving cell lines</p>
|
||||
<p> In research involving cell lines, the methods section of submissions should clearly state
|
||||
the
|
||||
source of the cell lines used. For established cell lines, the provenance should be
|
||||
provided,
|
||||
along with references to a published paper or commercial source. If the cell lines are of
|
||||
human
|
||||
origin, written informed consent must be obtained and documented. In the case of previously
|
||||
unpublished de novo cell lines, including those obtained from other laboratories, details of
|
||||
institutional review board or ethics committee approval must be included. This is especially
|
||||
important for cell lines derived from vulnerable or incapacitated participants, for whom
|
||||
written
|
||||
informed consent from a parent or guardian is required. Ensuring ethical conduct and proper
|
||||
oversight in research involving cell lines is vital.</p>
|
||||
|
||||
<p class="item-title"> 7.Research involving plants</p>
|
||||
<p>The well-being of many species of wild animals and plants is endangered due to climate change
|
||||
and overuse of natural resources, such as pangolins and rhinoceros horn. It is important
|
||||
that
|
||||
authors respect biodiversity and adhere to international treaties related to endangered
|
||||
species. If any pharmaceutical ingredients used in research come from endangered animals or
|
||||
plants, the source of these ingredients must be disclosed and ethical approval must be
|
||||
obtained.
|
||||
|
||||
<br />
|
||||
Experimental research on plants, whether cultivated or wild, must comply with institutional,
|
||||
national, or international guidelines. We recommend following the <a target="_blank"
|
||||
href="https://www.cbd.int/convention">Convention on Biological
|
||||
Diversity</a> and the <a target="_blank" href="https://cites.org/eng">Convention on the
|
||||
Trade in Endangered
|
||||
Species of Wild Fauna and Flora</a>.
|
||||
<br />
|
||||
For research manuscripts involving rare plants, voucher specimens must be deposited in an
|
||||
accessible herbarium or museum and genetic information and origin must be provided for each
|
||||
submitted manuscript. Ensuring the protection and preservation of biodiversity is crucial in
|
||||
research involving plants and animals.
|
||||
</p>
|
||||
<p class="item-title"> 8.Research data</p>
|
||||
<p> The length of time you store data depends on the nature of the research project and the
|
||||
resultant data. Where it is workable, you should store all data (for at least the term of
|
||||
the
|
||||
project). Most researchers will store data for at least five years after final publication.
|
||||
<br />
|
||||
You need to keep data for a further five years if you re-analyse data and publish again.
|
||||
</p>
|
||||
<p class="item-title">
|
||||
Intellectual property
|
||||
</p>
|
||||
<p> All journals of TMR Publishing Group adopt Gold Open Access, which allows the final version
|
||||
of
|
||||
an author's work to be freely and permanently accessible to all immediately after
|
||||
publication.
|
||||
This approach clears most permission barriers. Authors retain the copyright of their
|
||||
manuscripts. Journal adopt the Creative Commons Attribution (CC BY) license, this license
|
||||
allows
|
||||
reusers to distribute, remix, adapt, and build upon the material in any medium or format, so
|
||||
long as attribution is given to the creator, the license allows for commercial use. See:
|
||||
<a target="_blank"
|
||||
href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</a>
|
||||
</p>
|
||||
|
||||
|
||||
<p class="item-title"> Corrections, retractions, and expressions of concern
|
||||
</p>
|
||||
<p class="item-title"> 1.Published papers corrections</p>
|
||||
<p> TMR Publishing Group's "Published papers corrections" policy and process is open and
|
||||
transparent.</p>
|
||||
<p class="item-title"> a.Not eligible for corrections</p>
|
||||
<p> Minor errors that do not affect readability or meaning (eg spelling, grammar, whitespace
|
||||
errors)
|
||||
are not eligible for a correction, regardless of whether the error is caused by the author
|
||||
or
|
||||
editor.</p>
|
||||
<p class="item-title"> b.Eligible for corrections without posting a correction notice
|
||||
</p>
|
||||
<p> (1). The editorial office requires the author to confirm the author's information in the
|
||||
PROOF
|
||||
stage. Once the author's information is confirmed, the editor will not change it if it is
|
||||
not
|
||||
related to the spelling of the author's name. It may be done if it is deemed a reasonable
|
||||
request by the editorial office. Once approved, the article will be updated and republished
|
||||
on
|
||||
our website. After this, all relevant index databases will be notified to ensure that the
|
||||
database version has also been modified.<br />
|
||||
(2). Name changes are also permitted, and we recognize that name changes may be private in
|
||||
nature for a variety of reasons, which may include alignment with gender identity, marriage,
|
||||
divorce, or religious beliefs. Therefore, to protect authorship, no corrections will be
|
||||
published and no co-authors will be notified. Authors should contact the journal's editorial
|
||||
office to request a name change.<br />
|
||||
Although the above is the case of "Eligible for corrections without posting a correction
|
||||
notice", the revision process will be recorded in the TMR publishing group's submission
|
||||
system
|
||||
and retained for at least one year for retrospective use.
|
||||
<br />
|
||||
In the following cases, a corrections request can be completed, but a correction notice must
|
||||
be
|
||||
published.<br />
|
||||
(1). Error in a misleading section of an otherwise reliable publication; error in data or
|
||||
interpretation (that does not affect final conclusions); missing or unclear figures/tables.
|
||||
<br /> (2). Add or remove the author from the author list (including adding or removing
|
||||
entire
|
||||
affiliations).
|
||||
<br /> (3). Add or remove references.
|
||||
<br />(4). Add or remove text.
|
||||
<br />(5). Modification of funding, author contributions, acknowledgments.
|
||||
<br />Once the update request is approved, the article will be updated and republished on
|
||||
our website
|
||||
with the correction posted. The notice is a separate publication, linked to the updated
|
||||
article,
|
||||
registered as a separate DOI, but published in the latest issue of the journal. Following
|
||||
these
|
||||
updates, all relevant index databases will be notified to ensure that database versions are
|
||||
also
|
||||
revised.<br />
|
||||
</p>
|
||||
|
||||
<p class="item-title"> 2.Retractions</p>
|
||||
<p> There are many reasons for retractions, which may be due to inadvertent errors in the
|
||||
research
|
||||
process, serious ethical violations, falsified data, extensive plagiarism, or other reasons.
|
||||
Such articles threaten the integrity of the scientific record and need to be
|
||||
retracted. <br />
|
||||
TMR Publishing Group follows the <a target="_blank"
|
||||
href="https://publicationethics.org/retraction-guidelines">recommendation of the
|
||||
Committee
|
||||
on Publication Ethics
|
||||
(COPE)</a> to
|
||||
retract. If a retraction is published, the original publication is revised with a
|
||||
"Retraction"
|
||||
watermark, but is still available on the journal's website for future reference. However,
|
||||
retracted articles should not be cited and used for further research as they cannot be
|
||||
trusted. <br />
|
||||
The retraction notice will fully publish the information of the retracted paper and the
|
||||
reason
|
||||
for the retraction. The notice is a separate publication, linked to the retracted paper, and
|
||||
will be registered as a separate DOI, but published in the journal's latest issue. If the
|
||||
result
|
||||
is only partially wrong, a partial retraction may be published. <br />
|
||||
Only in very exceptional circumstances, the article will be completely removed from the
|
||||
website
|
||||
and related indexing databases. <br /></p>
|
||||
<p class="item-title"> 3.Expressions of concern</p>
|
||||
|
||||
<p> If an editor identifies significant issues with the interpretation or conclusions of a
|
||||
published
|
||||
article that could influence public understanding or policy, they may issue an Editorial
|
||||
Expression of Concern. This notice serves to inform the readership of ongoing, complex
|
||||
investigations or immediate concerns relevant to public health or policy. Such expressions
|
||||
are
|
||||
preliminary and may lead to further editorial actions like corrections or retractions, but
|
||||
they
|
||||
remain a permanent part of the article's record.</p>
|
||||
<p class="item-title"> Ensuring the integrity of the scholarly record</p>
|
||||
|
||||
|
||||
<p class="item-title"> 1.Plagiarism check</p>
|
||||
<p>TMR Publishing Group utilizes both Crossref Similarity Check and an AI tool developed by TMR
|
||||
Publishing Group to check for plagiarism in manuscripts. This will effectively help editors
|
||||
identify potentially problematic manuscripts. The editors' check of the similarity score is
|
||||
comprehensive, including whether the citations are reasonable, whether the sources of
|
||||
repetition
|
||||
are concentrated or from different sources, and so on. In most cases, the similarity rate of
|
||||
accepted articles is below 20%.</p>
|
||||
|
||||
<p class="item-title"> 2.Plagiarism, data fabrication and image manipulation</p>
|
||||
<p class="item-title"> a.Plagiarism</p>
|
||||
<p> Plagiarism is not acceptable. Plagiarism includes copying ideas, text, images, or data from
|
||||
another source without citing the original source, and even includes articles previously
|
||||
published by the author themselves. <br />
|
||||
If the design of research or the structure or language of a manuscript is inspired by
|
||||
previous
|
||||
research, those researches must be explicitly cited.
|
||||
</p>
|
||||
<p class="item-title"> b. Data fabrication</p>
|
||||
<p> We adopt the Recommended action by COPE for Journal Editors process for handling data
|
||||
falsification. <br />
|
||||
<a target="_blank"
|
||||
href="https://resource-cms.springernature.com/springer-cms/rest/v1/content/4162/data/v2">Suspected
|
||||
fabricated data in a submitted manuscript </a><br />
|
||||
<a target="_blank"
|
||||
href="https://resource-cms.springernature.com/springer-cms/rest/v1/content/4168/data/v2">Suspected
|
||||
fabricated data in a published article </a><br />
|
||||
</p>
|
||||
<p> c.Image manipulation</p>
|
||||
<p> Starting from May 24, 2023, for manuscripts submitted to our journal, authors are expected
|
||||
to
|
||||
provide the original, unaltered, and uncropped images that support all the blot and gel
|
||||
results
|
||||
presented in the figures and supporting information files. It is acceptable for the author
|
||||
to
|
||||
make adjustments to the brightness, contrast, or color balance of the image (if they are
|
||||
applied
|
||||
to the whole image and if they do not obscure, eliminate, or misrepresent any information
|
||||
present in the original, including backgrounds). However, no specific feature within an
|
||||
image
|
||||
may be enhanced, obscured, moved, removed, or introduced.
|
||||
</p>
|
||||
<p class="item-title">d. Citation policies</p>
|
||||
<p> Excessive self-citation, co-citation by multiple authors, unnecessary citation of articles
|
||||
published in submitting journals, and any other form of citation manipulation are
|
||||
inappropriate.
|
||||
Citation manipulation will result in the manuscript being rejected and possibly reported to
|
||||
the
|
||||
corresponding author's institution. Likewise, any attempts by reviewers or editors to
|
||||
encourage
|
||||
such practices should be reported by the author to the publisher.
|
||||
<br /> The author should consider the following guidelines when preparing the manuscript:
|
||||
<br /> (1). Any statement in the manuscript that relies on an external source of
|
||||
information (i.e. not
|
||||
the author's own new ideas or findings or general knowledge) should be cited.
|
||||
<br /> (2). Author should avoid citing derivative work of the original work.
|
||||
<br /> (3). Author should ensure that their citations are accurate.
|
||||
<br /> (4). Author should not cite sources they have not read.
|
||||
<br /> (5). Author should not use excessive citations to support a point.
|
||||
<br />(6). Ideally, author should cite articles from peer-reviewed sources whenever
|
||||
possible.
|
||||
</p>
|
||||
<p class="item-title"> Editorial board responsibilities</p>
|
||||
|
||||
<p>
|
||||
The Editorial Board plays a crucial role in enhancing the quality and integrity of the
|
||||
journal.
|
||||
Their expanded responsibilities encompass various aspects:
|
||||
<br /> Expert Guidance: Members provide essential scientific expertise, shaping the
|
||||
journal's content
|
||||
and strategic direction.
|
||||
<br /> Content Contribution: They actively contribute articles and solicit high-quality
|
||||
submissions
|
||||
from peers, increasing the journal's breadth and depth.
|
||||
<br /> Peer Review: Board members either oversee the peer review process or participate
|
||||
directly as
|
||||
reviewers, ensuring the rigor and fairness of evaluations.
|
||||
<br /> Promotion and Networking: They promote the journal within the scientific community,
|
||||
particularly
|
||||
at conferences and seminars, to attract groundbreaking manuscripts and foster
|
||||
collaborations.
|
||||
<br /> Developmental Feedback: Regular feedback on the journal's policies and practices is
|
||||
crucial, as
|
||||
it helps in refining operational and editorial strategies.
|
||||
<br /> Curating Content: They recommend themes for special issues and suggest potential
|
||||
authors for
|
||||
commissioned pieces, such as review articles and commentaries.
|
||||
<br /> Mentorship and Advice: New or existing members can always reach out to their journal
|
||||
contact for
|
||||
advice on structuring the Editorial Board effectively or resolving any procedural concerns.
|
||||
</p>
|
||||
|
||||
<p class="item-title"> Accessibility and digital archive</p>
|
||||
<p> TMR Publishing Group has entrusted the <a target="_blank"
|
||||
href="https://natlib.govt.nz/items?text=TMR+Publishing+Group&commit=Search">National
|
||||
Library of New
|
||||
Zealand</a> and <a target="_blank"
|
||||
href="https://www.portico.org/publishers/tmr/">Portico</a> to
|
||||
archivally
|
||||
preserve the content published in its journals. This arrangement ensures the long-term
|
||||
availability and accessibility of our published research and scholarship, and helps to
|
||||
safeguard
|
||||
the intellectual record for future generations. The National Library of New Zealand and
|
||||
Portico
|
||||
are recognized as reputable and reliable archival organizations, and we are confident in
|
||||
their
|
||||
ability to properly care for and maintain our published content. This arrangement is an
|
||||
important aspect of our commitment to the preservation and dissemination of knowledge, and
|
||||
we
|
||||
believe it is essential for supporting the ongoing advancement of research and scholarship
|
||||
in
|
||||
our field.</p>
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
<br><br><br><br>
|
||||
</div>
|
||||
</div>
|
||||
</div>
|
||||
<br clear="both">
|
||||
|
||||
</div>
|
||||
<div class="footer">
|
||||
<!--底部菜单栏-->
|
||||
</div>
|
||||
</div>
|
||||
</body>
|
||||
<script src="js/jquery.min.js"></script>
|
||||
<script src="js/return-top.js"></script>
|
||||
<script src="js/layer/layer.js"></script>
|
||||
<script src="js/js.js"></script>
|
||||
<script src="js/side.js"></script>
|
||||
<script>
|
||||
$(document).ready(function(){
|
||||
side_list();
|
||||
|
||||
$.ajax({
|
||||
type: 'post', url: apiUrl + 'api/Journal/getJournal',
|
||||
data: {
|
||||
"journal_id": Jour_num
|
||||
},
|
||||
success: function (result) {
|
||||
if (result.code == 0) {
|
||||
// 基本信息
|
||||
var arr_jour = result.data.journal;
|
||||
|
||||
$('.jour_name_title').html(arr_jour.title)
|
||||
$('.jour_name_website').html(arr_jour.email)
|
||||
$('.jour_name_editor').html(arr_jour.editorinchief)
|
||||
|
||||
|
||||
} else {
|
||||
// ShowDanger("请求失败!");
|
||||
}
|
||||
},
|
||||
error: function () {
|
||||
ShowDanger("error!");
|
||||
}
|
||||
})
|
||||
});
|
||||
|
||||
</script>
|
||||
</html>
|
||||
Reference in New Issue
Block a user